These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2516669)

  • 21. A 5-year study of patients with pulmonary tuberculosis treated at home in a controlled comparison of isoniazid plus PAS with 3 regimens of isoniazid alone.
    Evans C; Devadatta S; Fox W; Gangadharam PR; Menon NK; Ramakrishnan CV; Sivasubramanian S; Somasundaram PR; Stott H; Velu S
    Bull World Health Organ; 1969; 41(1):1-16. PubMed ID: 5309083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-course chemotherapy for pulmonary tuberculosis under routine programme conditions: a comparison of regimens of 28 and 36 weeks duration in Algeria. Algerian Working Group/British Medical Research Council Cooperative Study.
    Tubercle; 1991 Jun; 72(2):88-100. PubMed ID: 1949222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
    Lancet; 1975 Jan; 1(7899):119-24. PubMed ID: 46047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First-line chemotherapy in the retreatment of bacteriological relapses of pulmonary tuberculosis following a shortcourse regimen.
    Lancet; 1976 Jan; 1(7952):162-3. PubMed ID: 54680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Five-year follow-up of a clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1988 May; 137(5):1147-50. PubMed ID: 2904237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens.
    Jawahar MS; Rajaram K; Sivasubramanian S; Paramasivan CN; Chandrasekar K; Kamaludeen MN; Thirithuvathas AJ; Ananthalakshmi V; Prabhakar R
    Trop Med Int Health; 2005 Nov; 10(11):1090-8. PubMed ID: 16262733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis.
    Mitchison DA; Nunn AJ
    Am Rev Respir Dis; 1986 Mar; 133(3):423-30. PubMed ID: 2420242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ethambutol plus isoniazid for the treatment of pulmonary tuberculosis--a controlled trial of our regimens.
    Tubercle; 1981 Mar; 62(1):13-29. PubMed ID: 7022973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.
    Ige OM; Bakare NA; Onadeko BO
    Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary tuberculosis treated with isoprodian and rifampicin or pyrazinamide.
    Kleeberg HH
    Chemotherapy; 1987; 33(3):219-28. PubMed ID: 3297528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium.
    Vernon A; Burman W; Benator D; Khan A; Bozeman L
    Lancet; 1999 May; 353(9167):1843-7. PubMed ID: 10359410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
    Brändli O; Haegi V; Villiger B; Bohn W; Baumann HR; Zäch R
    Schweiz Med Wochenschr; 1989 Mar; 119(10):299-305. PubMed ID: 2652281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controlled clinical trial of four short-course regimens of chemotherapy for two durations in the treatment of pulmonary tuberculosis: first report: Third East African/British Medical Research Councils study.
    Am Rev Respir Dis; 1978 Jul; 118(1):39-48. PubMed ID: 79319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A controlled trial of 3-month, 4-month, and 6-month regimens of chemotherapy for sputum-smear-negative pulmonary tuberculosis. Results at 5 years. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council.
    Am Rev Respir Dis; 1989 Apr; 139(4):871-6. PubMed ID: 2648911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Supervised six-months treatment of newly diagnosed pulmonary tuberculosis using isoniazid, rifampin, and pyrazinamide with and without streptomycin.
    Snider DE; Graczyk J; Bek E; Rogowski J
    Am Rev Respir Dis; 1984 Dec; 130(6):1091-4. PubMed ID: 6508006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlled clinical trial of four 6-month regimens of chemotherapy for pulmonary tuberculosis. Second report. Second East African/British Medical Research Council Study.
    Am Rev Respir Dis; 1976 Sep; 114(3):471-5. PubMed ID: 788570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1985 Aug; 132(2):374-8. PubMed ID: 2862820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlled trial of 6-month and 9-month regimens of daily and intermittent streptomycin plus isoniazid plus pyrazinamide for pulmonary tuberculosis in Hong Kong. The results up to 30 months.
    Am Rev Respir Dis; 1977 May; 115(5):727-35. PubMed ID: 857713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlled clinical trial of three short-course regimens of chemotherapy for pulmonary tuberculosis in Nigeria--a preliminary report.
    Onadeko BO; Awotedu AA; Ogunbanjo BO; Aderinto EB
    Tubercle; 1986 Sep; 67(3):189-95. PubMed ID: 3535187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The therapeutic effect of regimens containing isoniazid and rifampicin for pulmonary tuberculosis with single isoniazid or rifampicin resistance].
    Tan S; Ding X; Tan Y; Cai X; Li Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Dec; 37(12):915-8. PubMed ID: 25609129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.